Cell

CAR-TCR

The CAR-TCR series is dedicated to accelerating the progress of CAR and TCR technologies and therapies that are safe, effective, and commercially successful in liquid and solid tumor indications, to engineer a cancer-free world.

Our targeted events bring together scientific and business leaders from large pharma, biotech & academia to overcome discovery, development and commercialization challenges affecting the delivery of these novel therapies to patients in need.


“Moments where we can come together with passionate individuals and companies who are focused on advancing cancer care are inspiring, and the CARTCR Summit is no different...”
Novartis